Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539278 | NSE Symbol : | ISIN : INE653R01012 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
31-Jan-2025	11-Feb-2025	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Kindly take note of the same on your records. pfa (As Per BSE Announcement Dated on 11/02/2025)
05-Nov-2024	12-Nov-2024	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Kindly take note of the same on your records. Kindly take note of the same on your records. Kindly take note of the same on your records. (As Per BSE Announcement dated on 12.11.2024)
29-Aug-2024	02-Sep-2024	AGM	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve Kindly take the same on record. Kindly take the same on records. (As Per BSE Announcement dated on 02.09.2024)
07-Aug-2024	14-Aug-2024	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015 consider and approve Unaudited Financial Result for quarter ended on 30th June 2024. 2. To consider and approve the Limited Review Report on the Financial Results for the quarter ended on 30th June 2024. 3. Any other matter with the permission of the Chairperson. Kindly take the same on record. (As Per BSE Announcement dated on 14.08.2024)
21-May-2024	30-May-2024	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Kindly take the matter on records. Kindly take on records. (As Per BSE Announcement Dated on 30.05.2024)
01-Feb-2024	13-Feb-2024	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Kindly take note of the same on your records. Kindly take the same on record. (As per BSE Announcement Dated on 13/02/2024)
31-Oct-2023	08-Nov-2023	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Kindly take note of the same on records. Kindly take note of the same on your records. Kindly take the above on record. (As Per BSE Announcement dated on 08.11.2023)
06-Oct-2023	09-Oct-2023	Change in Other Executives	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2023 inter alia to consider and approve Kindly take the same on record. Kindly take the above on record. Appointment of Company Secretary and Compliance Officer of the Company with effect from September 30, 2023. Kindly take the above on record. (As Per BSE Announcement Dated on 09/10/2023)
29-Aug-2023	05-Sep-2023	AGM	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015 (Listing Regulation ) We would like to inform you that the meeting of Board of Director of Symbiox Investment & Trading Co Ltd scheduled to be held on 5th September 2023 Tuesday at 4:00 P.M. at Registered Office of the Company to Inter-alia transact the following Matters: 1. To Consider and approve the Director Report and annexure thereof Management Discussion analysis and Corporate Governance Report for the Financial Year 2022-23. 2. To Consider and fix the dates for closure of Register of Members and Transfer books. 3. To Consider and fix day date time and venue and calendar of events and notice of 44th Annual General Meeting of the Company. 4. To take note on status of Statutory Registers maintained under Companies Act 2013. 5. To appoint Scrutinizer for conducting e- voting and poll process for 44th Annual General Meeting of the Company. Dear Sir/Madam, We wish to inform you that the 4th / 2023-24 meeting of the Board of Directors of Symbiox Investment & Trading Company Limited was held on Tuesday, 05th September, 2023 at the Registered Office of the Company. The Board has taken inter-alia the following decisions: -. 1. Approve the Director Report and annexure thereof, Management Discussion analysis and Corporate Governance Report for the Financial Year 2022-23. 2. Pursuant to Section 91 of the Companies Act, 2013, the Register of Members and share transfer books of the Company will remain closed from 23rd September, 2023 to 29th September, 2023 (both days inclusive) for the purpose of AGM. (As Per BSE Announcement Dated on 05/09/2023)
01-Aug-2023	12-Aug-2023	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Kindly take the above on record. Kindly take note of the above Kindly take the above on record. (As per BSE Announcement Dated on 12/08/2023)
20-May-2023	29-May-2023	Accounts	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Security Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015 (Listing Regulation ) We would like to inform you that the meeting of Board of Director of Symbiox Investment & Trading Co Ltd scheduled to be held on 29th May 2023 Monday at 04:30 P.M at Registered Office of the Company to Inter-alia transact the following Matters Dear Sir, We would like to inform you that the Meeting of Board of Directors of Symbiox Investment & Trading Co Ltd was held on 29th May, 2023 Monday at 04:30 P.M. at its registered office address to inter-alia transact the following matters: 1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audited Financial Results (Standalone) for the Quarter and Year ended on 31st March, 2023. 2. Adopted Auditor Report given by Statutory Auditor of the Company. M/s SSRV & ASSOCIATES. Chartered Accountant, Mumbai. 3. To consider and approve the Appointment of Mr. Akhil Agarwal, Practicing Company Secretary as Secretarial Auditor of the Company for the Financial Year 2023-24. 4. To Approve the Appointment of Om Prakash Khajanchi & Co.( FRN No. (FRN:330280E) as Internal Auditor of the Company. Dear Sir, This is to inform you that Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015, the Board of Directors of the company at their meeting held on 29th May, 2023, have approved the Audited Financial Results of the company for the quarter and Year ended 31th March, 2023. 1. Approved the Audited Financial Results (Standalone) for the Quarter and year ended on 31th March, 2023 as recommended by the Audit committee. 2. Auditor's Limited Review Report in the prescribed format issued by the Statutory Auditor of the Company also attached herewith. 3. Declaration for unmodified audit report in respect of Standalone financial statements for the year 2022-2023 under SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 Please take the same on your record and acknowledge the receipt of the same. Thanking You. Yours Faithfully, For Symbiox Investment & Trading Co Ltd SAMIT RAY Director DIN No: 08406285 (As Per BSE Announcement dated on 29.05.2023) This is to inform you that Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015, the Board of Directors of the company at their meeting held on 29th May, 2023, have approved the Audited Financial Results of the company for the quarter and Year ended 31th March, 2023. (As per BSE Announcement Dated on 09/06/2023)
08-Apr-2023	17-Apr-2023	Change in Other Executives	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/04/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Security Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015 (Listing Regulation ) We would like to inform you that the meeting of Board of Director of Symbiox Investment & Trading Co Ltd scheduled to be held on 17th April 2023 Monday at 12:30 P.M at Registered Office of the Company to Inter-alia transact the following Matters: 1. To consider and approve resignation of Neha Pansari ( M. No. 31763) Company Secretary of the Company . 2. Any other matter with the permission of the Chairperson. Please take the same on your record and acknowledge the receipt of the same. Thanking You. Yours Faithfully For Symbiox Investment & Trading Co Ltd Samit Ray Director DIN No. 08406285 Dear Sir, We would like to inform you that the Meeting of Board of Directors of Symbiox Investment & Trading Co Ltd was held on 17th April, 2023, Monday at 12:30 P.M. at its registered office address to inter-alia transact the following matters: 1. Approved the Resignation of Neha Pansari ( M. No. 31763) Company Secretary of the Company. 2. No any other matter with the permission of the Chairperson. Kindly note that the meeting of the Board of Directors commenced at 12:30 P.M and concluded at 01:00 P.M Please take the same on your record and acknowledge the receipt of the same. Thanking You. Yours Faithfully, For Symbiox Investment & Trading Co Ltd Samit Ray Director DIN No. 08406285 (As per BSE Announcement Dated on 17/04/2023) Resignation of Neha Pansari w.e.f. April 5, 2023. (As Per BSE Announcement Dated on 21.04.2023)
09-Feb-2023	17-Feb-2023	EGM	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/02/2023 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 17th February 2023 to inter alia consider and decide: 1. To Increase in Authorised Share Capital of the Company subject to approval of the shareholders. 2. To Approve the Notice of Extra-Ordinary General Meeting of the Company. 3. To Appoint the Scrutinizer for the purpose of Extra-Ordinary general meeting. 4. Any other matter with the permission of Chair. Please take the same on your record. Thanking you. Yours Faithfully For Symbiox Investment & Trading Co Ltd Neha Pansari Company Secretary M. No. 31763 Dear Sir/Madam, We hereby inform that the Board of Directors of the Company in its meeting held on 17th February, 2023 has considered and decided the following matters: 1) The Board has decided to increase the Authorized share capital of the company from Rs. 31,30,00,000 (Thirty-One Crore Thirty Lakhs) to Rs. 51,30,00,000 (Fifty One Crore Thirty Lakhs) divided into 5,13,00,000 (Five Crore Thirteen Lakh) Equity shares of Rs. 10/- each of the company and consequent alteration of Memorandum of Association of the Company, subject to approval of the Shareholders. 2) Adoption of new set of Article of Association as per Companies Act, 2013 3) Approve the Notice of Extra Ordinary General Meeting (EOGM) of the Company to be sent to the shareholders in relation to: - To Consider Increase of Authorized Share Capital and Alteration of Memorandum of Association of the Company. - Adoption of New Set of Articles of Association. - (As Per BSE Announcement Dated on 17.02.2023)
21-Jan-2023	30-Jan-2023	Quarterly Results	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve Dear Sir Pursuant to Regulation 29 of the Security Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015 (Listing Regulation ) We would like to inform you that the meeting of Board of Director of Symbiox Investment & Trading Co Ltd scheduled to be held on 30th January 2023 Monday at 01:00 P.M at Registered Office of the Company to Inter-alia transact the following Matters: 1. Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015 consider and approve Unaudited Financial Result for Quarter and Nine months ended on 31st December 2022. 2. To consider and approve the Limited Review Report on the Financial Results for the quarter and Nine Months ended on 31st December 2022. 3. Any other matter with the permission of the Chairperson. Please take the same on your record and acknowledge the receipt of the same. Dear Sir, This is to inform you that Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015, the Board of Directors of the company at their meeting held on 30th January, 2023, have approved the Unaudited Financial Results of the company for the quarter and nine months ended 31th December, 2022. 1. Approved the Unaudited Financial Results (Standalone) for the Quarter and nine months ended on 31th December, 2022 as recommended by the Audit committee. 2. Auditor's Limited Review Report in the prescribed format issued by the Statutory Auditor of the Company also attached herewith Please take the same on your record and acknowledge the receipt of the same. Thanking You. Yours Faithfully, For Symbiox Investment & Trading Co Ltd Neha Pansari Company Secretary M. No. 31763 Dear Sir, We would like to inform you that the Meeting of Board of Directors of Symbiox Investment & Trading Co Ltd was held on 30th January, 2023 Monday at 01:00 P.M. at its registered office address to inter-alia transact the following matters: 1. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Unaudited Financial Results (Standalone) for the Quarter and Nine months ended on 31st December, 2022. 2. Adopted Auditor Limited Review Report given by Statutory Auditor of the Company. M/s Manabendra Bhattacharyya & Co. Chartered Accountant, Kolkata. 3. To Approved and Appointment Statutory Auditor M/s S S R V & Associates, Chartered Accountant, Mumbai, FRN No. 135901W for 5 years and Resignation of M/s Manabendra Bhattacharyya & Co. Chartered Accountant, Kolkata as a Statutory Auditor of the Company (As Per BSE Announcement dated on 30.01.2023)
23-Dec-2022	05-Jan-2023	Right Issue	Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2023 inter alia to consider and approve Dear Sir This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 05th day of January 2023 to inter alia consider and decide fund raising by way of rights issue of equity shares or any other securities of the Company and for matters incidental thereto. Please take the same on your record. Thanking you. Yours Faithfully For Symbiox Investment & Trading Co Ltd Neha Pansari Company Secretary M. No. 31763 Dear Sir/Madam, The Board of Directors of the Company in its meeting held on 05th January, 2023 have considered and approved the following matters; 1) To raise Fund for an amount not exceeding Rs. 20,00,00,000/- (Rupees Twenty Crore only), through a Right Issue to the eligible equity shareholders of the Company as on Record date (to be notified subsequently), in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, SEBI Listing Regulations, along with relevant circulars issued by the Securities and Exchange Board of India, Companies Act, 2013 ('Right Issue'), subject to regulatory approval, if any. The rights issue will be either equity or any other convertible instruments. (As per BSE Announcement Dated on 05/01/2023)

1 2 3

LOGIN HERE

Symbiox Investment & Trading Co Ltd

Board Meeting